Amundi Grows Stock Position in National Health Investors, Inc. $NHI

Amundi increased its position in shares of National Health Investors, Inc. (NYSE:NHI) by 13.5% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 25,424 shares of the real estate investment trust’s stock after buying an additional 3,020 shares during the quarter. Amundi owned about 0.05% of National Health Investors worth $1,878,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in the company. Ameriprise Financial Inc. raised its position in National Health Investors by 34.8% in the fourth quarter. Ameriprise Financial Inc. now owns 30,598 shares of the real estate investment trust’s stock valued at $2,121,000 after purchasing an additional 7,894 shares during the period. Baird Financial Group Inc. acquired a new position in National Health Investors in the fourth quarter valued at $385,000. Focus Partners Wealth boosted its stake in National Health Investors by 4.0% in the fourth quarter. Focus Partners Wealth now owns 4,867 shares of the real estate investment trust’s stock valued at $337,000 after acquiring an additional 188 shares in the last quarter. Janus Henderson Group PLC raised its holdings in shares of National Health Investors by 12.0% in the fourth quarter. Janus Henderson Group PLC now owns 21,509 shares of the real estate investment trust’s stock valued at $1,491,000 after buying an additional 2,300 shares during the last quarter. Finally, Millennium Management LLC boosted its stake in shares of National Health Investors by 1,967.0% during the fourth quarter. Millennium Management LLC now owns 488,353 shares of the real estate investment trust’s stock worth $33,843,000 after buying an additional 464,727 shares during the period. Hedge funds and other institutional investors own 62.51% of the company’s stock.

National Health Investors Stock Down 1.1%

Shares of National Health Investors stock opened at $78.20 on Friday. The company has a fifty day moving average price of $74.15 and a 200 day moving average price of $73.50. The company has a current ratio of 10.91, a quick ratio of 10.91 and a debt-to-equity ratio of 0.75. National Health Investors, Inc. has a twelve month low of $65.13 and a twelve month high of $86.13. The stock has a market cap of $3.71 billion, a price-to-earnings ratio of 24.98, a price-to-earnings-growth ratio of 3.40 and a beta of 0.76.

National Health Investors (NYSE:NHI) last announced its quarterly earnings results on Wednesday, August 6th. The real estate investment trust reported $1.22 earnings per share for the quarter, topping analysts’ consensus estimates of $1.16 by $0.06. The firm had revenue of $70.27 million during the quarter, compared to analysts’ expectations of $86.46 million. National Health Investors had a net margin of 40.97% and a return on equity of 10.32%. The firm’s revenue was up 6.7% on a year-over-year basis. During the same period in the prior year, the company earned $1.18 EPS. Equities research analysts forecast that National Health Investors, Inc. will post 4.41 earnings per share for the current fiscal year.

National Health Investors Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Tuesday, September 30th will be given a $0.92 dividend. This represents a $3.68 dividend on an annualized basis and a yield of 4.7%. The ex-dividend date of this dividend is Tuesday, September 30th. This is an increase from National Health Investors’s previous quarterly dividend of $0.90. National Health Investors’s dividend payout ratio is currently 117.57%.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on the stock. Wedbush raised shares of National Health Investors to a “strong-buy” rating in a report on Wednesday, July 2nd. Wells Fargo & Company increased their target price on shares of National Health Investors from $76.00 to $80.00 and gave the company an “equal weight” rating in a report on Wednesday, August 27th. KeyCorp raised shares of National Health Investors from a “sector weight” rating to an “overweight” rating and set a $80.00 target price for the company in a report on Thursday, July 10th. Finally, Truist Financial increased their target price on shares of National Health Investors from $77.00 to $81.00 and gave the company a “buy” rating in a report on Friday, August 15th. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and one has given a Hold rating to the stock. According to MarketBeat, National Health Investors has a consensus rating of “Buy” and a consensus price target of $84.20.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.